and placebo the greatest (nausea 0.75, vomiting 0.61). A similar pattern of adjusted probabilities over neuromuscular blocking agents was seen for nausea and vomiting, with the greatest occurring in patients receiving pancuronium (nausea 0.74, vomiting 0.57) and the least in patients receiving alcuronium (nausea 0.59, vomiting 0.38). For country effects, the United Kingdom exhibited the greatest adjusted probability of nausea (0.75) and vomiting (0.54) and Germany the smallest (nausea 0.49, vomiting 0.34 
Postoperative nausea and vomiting are distressing and common occurrences after operative procedures requiring general anaesthesia [1] . It is believed that the frequencies of their occurrence have changed little in the past 30 years [1] . Many factors are thought to influence the frequencies, including the age of the patient, body weight, type of surgical procedure and the anaesthetic agents and techniques used [1, 2] . However, much of the evidence for variations in the frequencies of postoperative nausea and vomiting is not well documented. Indeed, studies published to date have often involved small numbers of patients and have used a variety of methodologies which have made it difficult to reach a clear consensus on the most important factors. Gynaecological surgery has been used often as a model in the evaluation of antiemetic drugs, yet little is known about the frequencies of nausea and vomiting associated with the various types of surgery involved. A series of multicentre clinical trials has recently been conducted in countries throughout Western Europe, to examine the efficacy of orally administered ondansetron (as ondansetron hydrochloride dihydrate) in the prevention of postoperative nausea and vomiting.
PATIENTS AND METHODS
Three multicentre, randomized, double-blind, placebo-controlled studies were conducted in seven countries throughout Western Europe. All had Regulatory and local Ethics Committee approval, and informed consent was obtained from each patient. The methodologies used in each study were identical. Patients aged 18-65 yr were studied, undergoing major gynaecological surgery using a standard general anaesthetic technique. Patients who were classed as ASA IV and V were excluded, as were patients who weighed less than 45 kg or more than 90 kg and those who were pregnant or breast feeding. In addition, patients who had experienced vomiting or who had taken antiemetic treatment during the previous 24 h were excluded. The use of intragastric tubes after operation was not permitted.
Patients were allocated randomly to receive one of three doses of active medication or placebo. Study medication was administered orally, the first dose approximately 1 h before induction of anaesthesia and the second and third doses 8 and 16 h after the first. Of 1442 patients recruited to the three studies, 1257 were evaluated: 420 received placebo and 212, 296 and 329 received ondansetron 1, 8 and 16 mg, respectively.
Premedication comprised temazepam 10-30 mg or diazepam 5-20 mg, administered either orally or rectally. Anaesthesia was induced using i.v. thiopentone 100-750 mg and maintained with nitrous oxide in oxygen supplemented with either 0.5-1.5% enflurane or 0.5-1.3% isoflurane, as required. Neuromuscular blocking agents were used as required and, if necessary, residual block was antagonized with atropine 0.5-2.5 mg and neostigmine 0.5-5.0 mg. Analgesia was provided using fentanyl 25-800 ug during operation and morphine 2-120 mg after operation, as required.
All observations were made without knowledge of whether or not the patient had received active treatment or placebo. Nausea and vomiting were assessed by direct questioning of the patient at 1, 4 and 24 h after recovery from anaesthesia, defined as the first response to spoken command. Retching was not assessed separately. If patients experienced emetic sequelae, rescue antiemetic treatment was available. Patients who received rescue antiemetics were classed as treatment failures and considered to have experienced both nausea and vomiting.
Factors measured in these studies which were considered to have a possible effect on the proportion of patients experiencing postoperative nausea and vomiting were examined. Using a process of elimination based on logistic regression techniques, the most important factors and their interactions were isolated. A model including these factors was then used to calculate adjusted probabilities of postoperative nausea and vomiting for each category of factor included in the model, to give an impression of the pattern of frequencies of postoperative nausea and vomiting across the factors. The variables measured were: patient age, volatile anaesthetic (enflurane or isoflurane), dose of morphine given for postoperative analgesia (divided into three dose categories), total dose of fentanyl given for analgesia at induction and during maintenance of anaesthesia (divided into two dose categories), country, duration of anaesthesia, neuromuscular blocker (alcuronium, atracurium, vecuronium or pancuronium), antagonists of neuromuscular block (neostigmine, other or none), premedication (diazepam or temazepam), time to recovery, type of surgery (vaginal hysterectomy, abdominal hysterectomy or laparotomy), antiemetic treatment (ondansetron 1, 8 or 16 mg, or placebo) and body weight. The influence of each of the three individual trials was not included, as the studies were carried out in different countries and therefore the effects attributable to trial and to country could not be separated.
Initially, logistic models of the proportions of patients experiencing postoperative nausea and vomiting containing all the above factors were fitted. A x 2 value for the overall fit of each model was obtained, together with the associated degrees of freedom. Further models were fitted, each excluding one factor. The difference between the x 2 value obtained from the model including all factors and that obtained from the model excluding a particular factor gave a measure of the importance of that factor in explaining the observed proportion of postoperative nausea or vomiting. The rank order of the resulting significance levels gave an indication of the order of importance of the factors.
Factors found to be important influences on both postoperative nausea and vomiting were included in all further models. Initially, these factors were fitted alone and a x 2 value for the model fit and the associated degrees of freedom obtained. Further models were fitted, each adding one of the remaining factors. The difference between the x 2 value obtained from the model including the original factors and that obtained from the model adding one particular factor gave a measure of the added importance of that factor in explaining the observed proportion of postoperative nausea or vomiting. Use of the rank order of the resulting significance levels gave an indication of the order of importance of the remaining factors.
Further examination of the effect of the above factors on the proportion of patients experiencing postoperative nausea and vomiting was undertaken using a stepwise fitting procedure. The levels of significance required of a variable for entry to and exit from the model were fixed at 10% beforehand, then variables were sequentially entered or removed from the model until no further variables met the required criterion for entry or exit. The variables included in the models obtained gave another indication of which factors were important influences on the proportions of postoperative nausea and vomiting.
When the important factors had been identified, two-way interactions between each pair of factors were investigated, using a method similar to that used to identify the important factors: initially a model containing just the factors was fitted, then further models, each including one two-way interaction. x 2 tests were again used to identify any important interactions. Higher level interactions were not investigated because of the large number of variables required.
All analyses were performed on an Olivetti M380 using PC SAS version 6.04.
RESULTS
A total of 1257 patients were evaluated for frequency of postoperative nausea and vomiting and all the factors included in this analysis. Four hundred and twenty received placebo and 212, 296 and 329 received ondansetron 1, 8 and 16 mg, respectively. Differences in the x 2 value obtained from the overall model and those obtained from models excluding each factor individually are presented in table I, for both vomiting and nausea. A significance level of P<0.10 was used to identify the most important factors. For vomiting these were (in order of increasing significance): antiemetic treatment, type of surgery, country, neuromuscular blocker and age. For nausea, the factors were antiemetic treatment, type of surgery, volatile anaesthetic and neuromuscular blocker. The three factors which were considered important for both vomiting and nausea (antiemetic treatment, type of surgery and neuromuscular blocker) were then included in all further models. Using a basic model including these three factors, further models were fitted, each including one of the remaining factors. The x 2 values, degrees of freedom Because premedicant had not seemed very important initially, the relationship between premedicant and other factors was investigated. It was found that all patients from four countries (Belgium, Denmark, France and Norway) and the majority of patients from two other countries (the Netherlands and Germany) received diazepam, whilst the majority of patients in the U.K. received temazepam. The effects of premedicant and country were therefore difficult to separate, and premedicant was excluded from further investigation.
Stepwise fitting was applied after constraining the model to include antiemetic treatment, type of surgery, neuromuscular block and country. The extra factors included in the final models were age for vomiting and volatile anaesthetic for nausea, which agreed with the factors identified in the initial elimination (table I). The model then used for investigation of interactions included antiemetic treatment, type of surgery, neuromuscular blocker, volatile anaesthetic and age.
A model including the factors identified as important using the above elimination procedures was fitted, and the x 2 values and degrees of freedom obtained. Further models, each including one twoway interaction between a pair of factors were fitted. The difference in the x 2 values obtained between the original model and a model including an interaction term provide a test for the statistical significance of the interaction. The only interaction found to be statistically significant for vomiting was type of surgery by age (P = 0.016). Whilst no interactions were significant at the 5 % level for nausea, the type of surgery by age interaction approached statistical significance (P = 0.073). This interaction was therefore included in the final model. The factors found to be important influences on the frequency of postoperative nausea and vomiting were thus antiemetic treatment, neuromuscular blocker, country, volatile anaesthetic, type of surgery and age, the last two factors showing a statistically significant interaction. Adjusted probabilities of nausea and vomiting were obtained from this model.
For adjusted probabilities of nausea and vomiting in each treatment group (table III), the ondansetron 8 mg group showed the smallest adjusted probability of nausea and of vomiting, and the placebo treatment group the greatest. For adjusted probabilities of experiencing nausea and vomiting in different countries (table IV) , the greatest probabilities occurred in the U.K. and the Netherlands. The rank order of countries by adjusted probability of postoperative nausea was similar to that seen for vomiting. The adjusted probability of nausea was greater than that for vomiting in each of the countries included. For neuromuscular blockers, the adjusted probabilities of nausea and vomiting were both smallest in the alcuronium group and greatest in the pancuronium group (table V) . Adjusted probabilities were slightly greater when anaesthesia had been maintained using isoflurane compared with enflurane (table V) .
The effects of age and type of surgery were found to have a statistically significant interaction, hence the individual effects of these factors could not be assessed in the study population as a whole. For display purposes, the continuous age variable has been grouped into three age categories. The adjusted probabilities of nausea and vomiting appeared to increase with increasing age for the abdominal hysterectomy and laparotomy types of surgery, but this pattern was not repeated for the vaginal hysterectomy type, for either nausea or vomiting (table VI). The observed interaction between age and type of surgery for vomiting may be explained in part by a very high adjusted probability of vomiting in patients who were aged 50 yr or more and had undergone laparotomy.
DISCUSSION
The combination of data obtained from these three large, international studies has allowed evaluation of several factors considered to influence the frequencies of postoperative nausea and vomiting. The statistical model developed indicates those factors having a more important influence. Whilst some indication of their relative importance was obtained, no direct statistical comparison of the levels of each factor was performed. The model obtained confirms the multifactorial nature of the occurrence of postoperative nausea and vomiting and illustrates the possibility of interactions between the different influences; it may be used to support or challenge published findings concerning influences in this area.
Postoperative nausea and vomiting are amongst the most common symptoms reported after surgery and the adjusted probabilities of experiencing nausea and vomiting in the placebo group (0.75 and 0.61, respectively) are not dissimilar to incidences reported previously after major gynaecological surgery [3] [4] [5] .
Currently, little information is available on the variation in the frequencies of postoperative nausea and vomiting between countries. Although anecdotal reports suggest postoperative nausea and vomiting are rarely seen in some countries, it would appear that there are significant problems in all the countries included in the present study, although the symptoms may be encountered slightly less frequently in some countries than in others. The reasons for these variations are unclear at present, but may represent subtle variations in anaesthetic practice or postoperative care not accounted for in the present study.
The probabilities of experiencing postoperative nausea and vomiting are generally believed to decrease with increasing age of the patient [1, 2] . Indeed, it has been shown that children are more likely to vomit after operation than adults [6] . However, the influence of age may not be as clear when an adult population is studied. The interaction between age and type of surgery found in this study prevented isolation of the influence of age alone. However, it appeared that the adjusted probabilities of nausea and vomiting increased with increasing age for abdominal hysterectomy and laparotomy. Similarly, the influence of type of surgery alone could not be isolated, although laparotomy appeared to result in generally smaller probabilities of postoperative nausea and vomiting than abdominal or vaginal hysterectomy. A lack of clear effect of age on nausea and vomiting has been observed previously by Knapp and Beecher [7] , who were unable to detect any effects of age on postoperative nausea and vomiting. More recently, van den Berg, Lambourne and Clyburn were unable to demonstrate an effect of age on postoperative vomiting after ophthalmic surgery [8] .
Maintenance of anaesthesia with enflurane resulted in slightly smaller adjusted probabilities of experiencing nausea and vomiting than did maintenance with isoflurane. These differences are probably of little clinical significance. In the few studies in which comparison of the incidence of postoperative nausea and vomiting has been made after anaesthesia with halothane, enflurane and isoflurane, no significant difference between the agents was observed [9] .
The type of neuromuscular blocker used appeared to influence the probability of experiencing nausea and vomiting, patients who received pancuronium being most likely to suffer nausea or to vomit. The reasons why varying proportions of patients should experience nausea and vomiting after different myoneural blockers are unclear. However, a possible explanation for patients having a greater probability of nausea and vomiting after receiving pancuronium may be its sympathomimetic activity. A greater incidence of nausea and vomiting is observed with drugs which are known to release endogeneous catecholamines [10] . Pancuronium, unlike other non-depolarizing neuromuscular blockers, releases noradrenaline, which may be an additional influencing factor [11] .
Use of neostigmine to antagonize neuromuscular block has previously been reported to result in an increased frequency of postoperative nausea and vomiting [12] , although this finding was not supported in the present study. The reason for this discrepancy is unclear, although King and colleagues [12] performed their study in 38 patients who were undergoing orthopaedic surgery, while the present study was performed in a much larger population who underwent gynaecological surgery.
Body weight has been reported to influence the frequencies of postoperative nausea and vomiting [1, 2] . McKenzie and colleagues [13] found increasing frequencies of nausea, retching and vomiting with increasing body weight in patients receiving general anaesthesia for therapeutic abortion. In the present study, however, we were unable to detect any influence of body weight. This may have been caused by the fact that restrictions were placed on the entry criteria which excluded patients weighing less than 45 kg or more than 90 kg.
The duration of anaesthesia has often been linked with postoperative nausea and vomiting [1, 2] , with patients considered to be more likely to vomit after operations of longer duration [14] . There did not appear to be any influences caused by the duration of anaesthesia in the present study (median 90 (interquartile range 65-120) min). The lack of effect may be explained by the fact that only a limited number of surgical procedures was included. Interestingly, Karlsson, Larsson and Nilsson [15] were unable to demonstrate an increase in the frequency of postoperative nausea with increasing duration of anaesthesia in a study of paediatric patients in whom anaesthesia was maintained with halothane. The present study has described the development of a statistical model for evaluating the importance of factors considered to influence the incidence of postoperative nausea and vomiting. In the population studied, this process has highlighted a number of factors such as duration of anaesthesia and body weight which may not be as important as originally thought. Further controlled studies using similar statistical techniques can help to confirm the findings from this study and establish which of the various influences may be clinically of most importance. Other factors such as previous history of postoperative nausea and vomiting, preoperative anxiety, pain, ambulation and timing of oral intake, which were not included in the current investigation, could be the subject of future research.
